Sino Biopharmaceutical | 1177 - Capital Social Ordinario

Precio De Mercado
5.54
Cambio Diario
-0.14 -2.46%
Mensual
-5.30%
Anual
44.27%
Q2 Expectativa
5.50




Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Jiangsu Hengrui CNY 6.64B 0 2026-03
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12